Health Canada approves Lipocine's TLANDO for testosterone replacement therapy

Health Canada has approved TLANDO capsules for testosterone replacement therapy in adult men with hypogonadism. Verity Pharma holds exclusive North American commercial rights and targets a Canadian launch by end-2026.